Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Anrikefon-based Patient-controlled Intravenous Analgesia for Pain Management After Laparoscopic Surgery: a Randomized, Double-blind, Active-controlled Pilot Tria

NCT07525986 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07525986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07525986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Anrikefon-based Patient-controlled Intravenous Analgesia for Pain Management After Laparoscopic Surgery: a Randomized, Double-blind, Active-controlled Pilot Tria
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
April 14, 2026
Completion date
April 30, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anrikefon, laparoscopic surgery, patient-controlled intravenous analgesia, visceral pain, postoperative